The Impact of Concurrent Training on Women Experiencing Symptoms of Menopause
Impact of Concurrent Training on Physical and Psychological Health in Women Experiencing Menopause
1 other identifier
interventional
90
1 country
1
Brief Summary
The aim of this study is to examine the impact of a concurrent training exercise intervention on menopausal symptoms and key physical and mental health outcomes. The proposed study is powered based on a primary outcome of examining the change in menopausal symptoms using the MenQoL questionnaire. Participants (n=70) will be randomised to an intervention or control group. The intervention group will participate in a 12 week online (via zoom) concurrent training programme, consisting of three forty-five minute sessions (on non-consecutive days) per week that align with WHO exercise recommendations for adults and the control group will maintain their regular activity. The exercise classes will be delivered by qualified Sport \& Exercise Scientists and will consist of a combination of bodyweight and resistance band exercises. Each class will consist of a 5 minute warm up, 15 minutes of aerobic exercise, 20 minutes of resistance training, and a 5 minute cool-down. Both groups will engage in pre and post testing through questionnaires (GAD-7, Patient Health Questionnaire-9 (PHQ-9), Menopause-Specific Quality of Life Questionnaire (MENQOL), Body Appreciation (BAS-2)), Pittsburgh Sleep Quality Index Sleep, International physical activity questionnaire (IPAQ), Body image questionnaire (BAS-2) and physical tests (Bod pod, grip-strength, 3-RM leg press, 3-RM cable pull, counter-movement jump and Astrand Rhyming submaximal aerobic test).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2025
CompletedStudy Start
First participant enrolled
December 12, 2025
CompletedFirst Posted
Study publicly available on registry
February 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2027
February 18, 2026
October 1, 2025
2 years
December 1, 2025
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Menopause Symptoms (Menopause-Specific Quality of Life Questionnaire)
29 symptoms of menopause are listed. For each symptom participants are asked to indicate whether they have experienced the symptom in the past month. If they have experienced it they will be asked to rate (on a scale of 0-6) how much they have been bothered by that symptom (0=not bothered at all; 6=extremely bothered).
Baseline testing (within 2 weeks prior to intervention start date) and post testing (within 2 weeks post intervention end date)
Secondary Outcomes (14)
Anxiety (GAD-7)
Baseline testing (within 2 weeks prior to intervention start date) and post testing (within 2 weeks post intervention end date)
Depression (Patient Health Questionnaire - 9)
Baseline testing (within 2 weeks prior to intervention start date) and post testing (within 2 weeks post intervention end date)
Pittsburgh Sleep Quality Index
Baseline testing (within 2 weeks prior to intervention start date) and post testing (within 2 weeks post intervention end date)
Body Appreciation Scale
Baseline testing (within 2 weeks prior to intervention start date) and post testing (within 2 weeks post intervention end date)
International Physical Activity Questionnaire
Baseline testing (within 2 weeks prior to intervention start date) and post testing (within 2 weeks post intervention end date)
- +9 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALControl
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Women experiencing perimenopause (irregular menstrual cycles of ≥7-day difference in cycle length of consecutive menstrual cycles) and early postmenopause (\< 5 years post menopause).
- Able to safely engage in a concurrent training interventions that combine both aerobic and resistance training.
- Must have reliable internet access and a device capable of participating in online training on zoom.
- Willingness and ability to provide informed consent and comply with study procedures.
- Aged between 40 and 60 years
You may not qualify if:
- BMI \>35 and \<18.5.
- Currently taking psychotropic medication
- Has undergone a hysterectomy
- Current substance abuse
- Current diagnosis of a mental health disorder
- Current diagnosis of a chronic illness
- Currently participating in other structured exercise programmes.
- Recent surgery or hospitalisation in the past 6 months.
- Currently taking hormonal contraceptive
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University College Dublin
Dublin, Dublin, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Mr
Study Record Dates
First Submitted
December 1, 2025
First Posted
February 18, 2026
Study Start
December 12, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 15, 2027
Last Updated
February 18, 2026
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- 01/01/2026 to 01/01/2029
Happy to share everything